SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
  
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
snyderman nancy lynn MD
(Last) (First) (Middle)
CONNAUGHT HOUSE
1 BURLINGTON ROAD
(Street)
DUBLIN 4 Ireland
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alkermes plc. [ ALKS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
05/31/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non Qualified Stock Option (Right to Buy)(1) $46.72 11/17/2023 J V 548 (2) 09/14/2026 Ordinary Shares 548 $46.72 27,948 D
Non Qualified Stock Option (Right to Buy)(1) $46.72 11/17/2023 J V 324 (2) 09/14/2026 Ordinary Shares 324 $46.72 16,524 D
Non Qualified Stock Option (Right to Buy)(1) $57.11 11/17/2023 J V 284 (2) 05/24/2027 Ordinary Shares 284 $57.11 14,484 D
Non Qualified Stock Option (Right to Buy)(1) $44.75 11/17/2023 J V 350 (2) 05/23/2028 Ordinary Shares 350 $44.75 17,850 D
Non Qualified Stock Option (Right to Buy)(1) $24.55 11/17/2023 J V 448 (2) 05/22/2029 Ordinary Shares 448 $24.55 22,848 D
Non Qualified Stock Option (Right to Buy)(1) $16.52 11/17/2023 J V 256 (2) 05/20/2030 Ordinary Shares 256 $16.52 13,079 D
Non Qualified Stock Option (Right to Buy)(1) $18.45 11/17/2023 J V 230 (2) 12/02/2030 Ordinary Shares 230 $18.45 11,739 D
Non Qualified Stock Option (Right to Buy)(1) $24.24 11/17/2023 J V 313 (2) 06/14/2031 Ordinary Shares 313 $24.24 15,990 D
Non Qualified Stock Option (Right to Buy)(1) $30.86 11/17/2023 J V 231 (2) 07/07/2032 Ordinary Shares 231 $30.86 11,785 D
Non Qualified Stock Option (Right to Buy)(1) $30.72 11/17/2023 J V 254 06/29/2024(3) 06/29/2033 Ordinary Shares 254 $30.72 12,986 D
Restricted Stock Unit Award(1) (4) 11/17/2023 J V 119 06/29/2024(5) (5) Ordinary Shares 119 (4) 6,104 D
Restricted Stock Unit Award (4) 05/31/2024 A 8,013 05/31/2025(6) (6) Ordinary Shares 8,013 $0 8,013 D
Non Qualified Stock Option (Right to Buy) $23.4 05/31/2024 A 17,492 05/31/2025(7) 05/31/2034 Ordinary Shares 17,492 $0 17,492 D
Explanation of Responses:
1. Represents an equity award granted prior to the separation of the issuer's oncology business into Mural Oncology plc (the "Separation"), as adjusted on November 17, 2023 in connection with the Separation (in order to preserve the value associated with the original award) based on the equity adjustment terms set forth in the Employee Matters Agreement filed by the issuer as Exhibit 10.2 to its Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 15, 2023. The exercise price (if any) of the adjusted award is shown in Boxes 2 and 8, the number of shares subject to the adjusted award is shown in Box 9 and the number of shares added to the award pursuant to the adjustment is shown in Box 5.
2. These options are fully vested in accordance with their terms.
3. Shares subject to the stock option award vest and become exercisable in full on 6/29/2024.
4. Each restricted stock unit represents a contingent right to receive one ordinary share.
5. Shares subject to the restricted stock unit award vest in full on 6/29/2024.
6. Shares subject to the restricted stock unit award vest in full on 5/31/2025.
7. Shares subject to the stock option award vest and become exercisable in full on 5/31/2025.
Remarks:
EXHIBIT LIST: Exhibit 24.1 - Power of Attorney
/s/ Shantale Greenson, attorney-in-fact for Nancy Snyderman 06/04/2024
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.